摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(13S)-13-methyl-3-phosphanyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

中文名称
——
中文别名
——
英文名称
(13S)-13-methyl-3-phosphanyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
英文别名
——
(13S)-13-methyl-3-phosphanyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one化学式
CAS
——
化学式
C18H23O2P
mdl
——
分子量
302.3
InChiKey
WOQAHTBHFYSTFD-GUZDXLFXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • PROCESS FOR THE PRODUCTION OF ESTETROL INTERMEDIATES
    申请人:ESTETRA S.A.
    公开号:US20140107091A1
    公开(公告)日:2014-04-17
    The present invention relates to a process for the preparation of a compound of formula (I) comprising the steps of a) reacting a compound of formula (II) with a silylating or an acylating agent to produce compound of formula (III), wherein P 1 is a protecting group selected from R 2 Si—R 3 R 4 or R 1 CO—, R 1 is a group selected from C 1-6 alkyl or C 3-6 cycloalkyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C 1-4 alkyl; R 2 , R 3 and R 4 are each independently a group selected from C 1-6 alkyl or phenyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C 1-4 alkyl; b) halogenation or sulfinylation of the compound of formula (III) to produce a compound of formula (IV); wherein X is halo, or —O—SO—R 5 , and R 5 is a group selected from C 6-10 aryl or heteroaryl, each group being optionally substituted by one or more substituents independently selected from chloro or C 1-4 alkyl; c) dehalogenation or desulfinylation of the compound of formula (IV) to produce compound of formula (V); and d) reacting the compound of formula (V) with a reducing agent to produce compound of formula (I).
    本发明涉及一种制备式(I)化合物的方法,包括以下步骤:a)将式(II)化合物与化剂或酰化剂反应,生成式(III)化合物,其中P1是从R2Si—R3R4或R1CO—中选择的保护基,R1是从C1-6烷基或C3-6环烷基中选择的基团,每个基团都可以被一个或多个取代基独立地选择,所述取代基选择自或C1-4烷基;R2、R3和R4各自独立地是从C1-6烷基或苯基中选择的基团,每个基团都可以被一个或多个取代基独立地选择,所述取代基选择自或C1-4烷基;b)卤代或亚磺酰化式(III)化合物,生成式(IV)化合物;其中X是卤素或—O—SO—R5,R5是从C6-10芳基或杂环芳基中选择的基团,每个基团都可以被一个或多个取代基独立地选择,所述取代基选择自或C1-4烷基;c)去卤代或去亚磺酰化式(IV)化合物,生成式(V)化合物;以及d)将式(V)化合物与还原剂反应,生成式(I)化合物。
  • Process for the Production of Estetrol
    申请人:Estetra S.P.R.L.
    公开号:US20140243539A1
    公开(公告)日:2014-08-28
    The present invention relates to a process for the preparation of a compound of formula (I), hydrates or solvates thereof.
    本发明涉及一种制备公式(I)化合物及其合物或溶剂化物的过程。
  • Process for the production of estetrol intermediates
    申请人:Pascal Jean-Claude
    公开号:US11053274B2
    公开(公告)日:2021-07-06
    The present invention relates to a process for the preparation of a compound of formula (I) said process comprising the steps of: a) reacting a compound of formula (II), with an acylating or a silylating agent to produce a compound of formula (III), wherein P1 and P2 are each independently a protecting group selected from R2—Si—R3R4, or R1CO—, wherein R1 is a group selected from C1-6alkyl or C3-6cycloalkyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; R2, R3 and R4 are each independently a group selected from C1-6alkyl or phenyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; b) reacting the compound of formula (III) in the presence of palladium acetate or a derivative thereof to produce compound of formula (IV); and c) reacting the compound of formula (IV) with a reducing agent to produce compound of formula (I).
    本发明涉及一种制备式(I)化合物的工艺,所述工艺包括以下步骤:a) 式(II)化合物与酰化剂或硅烷化剂反应生成式(III)化合物,其中 P1 和 P2 各自独立地为选自 R2-Si-R3R4 或 R1CO- 的保护基团,其中 R1 为选自 C1-6 烷基或 C3-6 环烷基的基团,每个基团可任选被一个或多个独立选自或 C1-4 烷基的取代基取代;R2、R3 和 R4 各自独立地为选自 C1-6 烷基或苯基的基团,每个基团任选被一个或多个独立选自或 C1-4 烷基的取代基取代; b) 在乙酸或其衍生物存在下使式 (III) 化合物反应,生成式 (IV) 化合物;以及 c) 使式 (IV) 化合物与还原剂反应,生成式 (I) 化合物。
  • US8987484B2
    申请人:——
    公开号:US8987484B2
    公开(公告)日:2015-03-24
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B